Calliditas Therapeutics AB (publ)
SSE:CALTX.ST
107.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 973.733 | 1,249.094 | 955.507 | 996.304 | 753.54 | 646.175 | 57.352 | 24.241 | 25.162 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 973.733 | 1,249.094 | 955.507 | 996.304 | 753.54 | 646.175 | 57.352 | 24.241 | 25.162 |
| Net Receivables
| 188.189 | 159.462 | 56.375 | 17.746 | 46.586 | 1.63 | 0.165 | 0.352 | 0.234 |
| Inventory
| 20.428 | 3.647 | 0.889 | 0 | 18.686 | -1.466 | 0 | 0 | 0 |
| Other Current Assets
| 92.802 | 0.001 | 0.001 | 22.801 | 2.32 | 1.63 | 4.272 | 2.205 | 2.376 |
| Total Current Assets
| 1,275.152 | 1,412.204 | 1,012.772 | 1,036.851 | 821.132 | 647.969 | 61.789 | 26.798 | 27.772 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 54.239 | 31.92 | 39.609 | 5.407 | 6.063 | 0.107 | 0.158 | 0.209 | 0.065 |
| Goodwill
| 48.584 | 45.8 | 37.2 | 445.301 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 430.754 | 438.041 | 362.218 | 16.066 | 16.066 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 479.338 | 483.841 | 399.418 | 461.367 | 16.066 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 24.201 | 11.21 | 3.915 | 2.225 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Tax Assets
| 67.619 | 13.799 | 4.196 | 0.6 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | 0 | 0 | 0 | 1.938 | 0.34 | 0.34 | 0.29 | 0.29 |
| Total Non-Current Assets
| 625.397 | 540.77 | 447.138 | 469.599 | 24.068 | 0.448 | 0.499 | 0.5 | 0.356 |
| Total Assets
| 1,900.549 | 1,952.973 | 1,459.91 | 1,506.45 | 845.2 | 648.417 | 62.288 | 27.298 | 28.128 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 100.564 | 160.404 | 67.971 | 53.827 | 24.384 | 22.643 | 13.684 | 4.922 | 3.107 |
| Short Term Debt
| 12.537 | 10.374 | 50.166 | 3.908 | 2.486 | 0 | 0.47 | 30 | 0 |
| Tax Payables
| 6.167 | 5.684 | 1.221 | 0.518 | 0.077 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 6.167 | -10.374 | 3.387 | -3.908 | 0.874 | 0 | 14.275 | 5.75 | 0 |
| Other Current Liabilities
| 287.876 | 164.827 | 13.922 | 51.792 | 25.626 | 7.599 | 0.683 | 0.849 | 6.934 |
| Total Current Liabilities
| 407.144 | 325.231 | 135.446 | 105.619 | 53.37 | 30.242 | 29.112 | 41.521 | 10.041 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 939.508 | 728.822 | 213.216 | 0.878 | 3.584 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 27.088 | 4.35 | 17.713 | -0.878 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 82.945 | 39.752 | 30.856 | 79.996 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 109.058 | 88.555 | 54.398 | 64.535 | 0.175 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1,158.599 | 861.479 | 316.183 | 144.531 | 3.759 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 1,565.743 | 1,186.71 | 451.629 | 250.15 | 57.129 | 30.242 | 29.112 | 41.521 | 10.041 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 2.383 | 2.383 | 2.094 | 1.998 | 1.548 | 1.408 | 0.667 | 0.531 | 0.455 |
| Retained Earnings
| -2,305.573 | -1,827.01 | -1,453.554 | -918.596 | -488.096 | -455.518 | -320.41 | -233.126 | -176.213 |
| Accumulated Other Comprehensive Income/Loss
| -5.231 | 9.307 | -26.979 | -6.09 | -0.045 | -0.034 | -0.04 | -0.036 | 0.086 |
| Other Total Stockholders Equity
| 2,643.227 | 2,581.583 | 2,486.72 | 2,133.179 | 1,274.664 | 1,072.319 | 352.959 | 218.408 | 193.759 |
| Total Shareholders Equity
| 334.806 | 766.263 | 1,008.281 | 1,210.491 | 788.071 | 618.175 | 33.176 | -14.223 | 18.087 |
| Total Equity
| 334.806 | 766.263 | 1,008.281 | 1,256.3 | 788.071 | 618.175 | 33.176 | -14.223 | 18.087 |
| Total Liabilities & Shareholders Equity
| 1,900.549 | 1,952.973 | 1,459.91 | 1,506.45 | 845.2 | 648.417 | 62.288 | 27.298 | 28.128 |